EUVIMEDEUVIMED entdecken
Crossref

Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk

Yoshito Matsuo, Shiro Sugiura, Seiya Masukane, Fumi Tanaka, Atsushi Makino, Katsumasa Kitamura, Teruaki Matsui, Yoshihiro Takasato, Komei Ito

International Archives of Allergy and Immunology · 2024

DOI: 10.1159/000542796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Yoshito Matsuo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan, sbqxg502@yahoo.co.jp. Hauptthemen laut MEDLINE: Milk Hypersensitivity, Desensitization, Immunologic, Allergens. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We previously reported the result of slow low-dose oral immunotherapy (SLOIT), which is a 1-year severity-stratified low-dose OIT for severe cow’s milk (CM) allergy (CMA) (threshold dose ≤287 mg of cumulative CM protein at the entry oral food challenge [OFC]). After completing the SLOIT protocol (exit OFC to cumulative 287 mg of CM protein), the participants were instructed to gradually increase the amount of CM, roughly doubling the increasing pace, if they could consume it symptom free for 2–3 months (SLOIT plus). This study evaluated the long-term outcomes of SLOIT and identified the factors associated with these outcomes.

Methods

The subjects were 23 children who completed the SLOIT protocol and proceeded with the SLOIT-plus instructions. The proportion of subjects who were desensitized to the full dose (FD; 200 mL of CM) was evaluated. Additionally, factors associated with FD 3 years after SLOIT (FD group) were analyzed. The allergic symptoms provoked in the OFC were quantified using the total score (TS) of the Anaphylaxis Scoring Aichi (ASCA), and the overall severity was expressed as TS/Pro (TS/cumulative protein dosage).

Results

The number of subjects who were desensitized to FD within 12, 24, and 36 months was 0 (0%), 3 (13%), and 8 (35%), respectively. The FD group exhibited a larger decrease in TS/Pro, IgE specific to CM, and casein after the SLOIT protocol.

Conclusion

A third of the children with severe CMA were desensitized to FD within 36 months after SLOIT. A better response to the 1-year SLOIT protocol was associated with better long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk HypersensitivityDesensitization, ImmunologicAllergensHumansFemaleMaleAdministration, OralAnimalsChildTreatment OutcomeChild, PreschoolCattleMilkImmunoglobulin EInfant

Stichwörter der Autor:innen

Cow’s milk allergyImmunotherapyLong termLow doseShared decision-making

Substanzen

AllergensImmunoglobulin E

Autor:innen und Institutionen

  • Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan, sbqxg502@yahoo.co.jp.
  • Department of Allergy, Allergy and Immunology Center, Aichi Children's Health and Medical Center, Aichi, Japan.

Zitieren

APA

Matsuo, Y., Sugiura, S., Masukane, S., Tanaka, F., Makino, A., Kitamura, K., Matsui, T., Takasato, Y., & Ito, K. (2024). Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk. International Archives of Allergy and Immunology. https://doi.org/10.1159/000542796

Vancouver

Matsuo Y, Sugiura S, Masukane S, Tanaka F, Makino A, Kitamura K, et al. Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk. International Archives of Allergy and Immunology. 2024. doi:10.1159/000542796

BibTeX
@article{Matsuo2024,
  author = {Matsuo, Yoshito and Sugiura, Shiro and Masukane, Seiya and Tanaka, Fumi and Makino, Atsushi and Kitamura, Katsumasa and Matsui, Teruaki and Takasato, Yoshihiro and Ito, Komei},
  title = {Long-Term Outcomes after Slow Low-Dose Oral Immunotherapy for Cow’s Milk},
  journal = {International Archives of Allergy and Immunology},
  year = {2024},
  doi = {10.1159/000542796}
}
Kostenlos starten →